Comment
Author: Admin | 2025-04-28
If a drug is not listed below it cannot automatically be assumed it is safe to coadminister HIV Drugs Selected HIV Drugs will be displayed here. 0"> Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} {{indicationName.name}} - Selected Indication Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0">Trade Name: {{vm.getTradeNames(drug)}} Full Listing 0"> Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">HEP Types: {{vm.getIndicationNames(drug)}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Co-medications Selected Co-medications will be displayed here. 0"> Drug Class: {{drug.drug_class_name || 'Not Available'}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0 && vm.language() === 'en'">Trade Name: {{vm.getTradeNames(drug)}} Drug Class: {{drug.drug_class_name || 'Not Available'}} 0">Trade Name: {{vm.getTradeNames(drug)}} Check HIV/ HIV drug interactions Drug Interactions will be displayed here Potential Weak Interaction Clicking on a symbol will give further information on the interaction. If a combination has not been assessed (either by study or within the product label), an interaction has been predicted based on the metabolic profiles of the drugs. These drugs should not be coadministered. Potential clinically significant interaction that is likely to require additional monitoring, alteration of drug dosage or timing of administration. Potential interaction likely to be of weak intensity. Additional action/monitoring or dosage adjustment is unlikely to be required. No clinically significant interaction expected. {{vm.tableDrugName(col)}} {{row.name}} {{col.primary_drug_name}} {{row.co_drug_name}} Generate a personalised report in PDF format
Add Comment